3D Bioprinting for Tumor Microenvironment Reconstruction: Advances, Challenges, and Future Perspectives
Biotechnology Journal · 2026
DOI: 10.1002/biot.70267 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biotechnology Journal, 2026. Verfasst von Ling-Jun Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Bioprinting, Printing, Three-Dimensional, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Cancer remains a major global health burden, and the disconnect between preclinical models and clinical outcomes continues to hinder progress in oncology. Conventional two‐dimensional (2D) cell cultures fail to recapitulate the in vivo tumor microenvironment (TME) and consequently show poor predictive power for drug responses. Animal models provide systemic insights but are constrained by interspecies differences, limited throughput, and high costs. Advanced three‐dimensional (3D) in vitro platforms, such as spheroids, organoids, and organ‐on‐chip systems, have improved physiological relevance; however, they often lack the spatial control, reproducibility, and integrative capacity needed to capture the full complexity of the TME. This review posits that the unique value of 3D bioprinting in cancer research lies in its ability to reproducibly integrate the multicomponent complexity of the TME within a controllable spatial framework, a capability that no existing 3D model can provide simultaneously. We outline the technical foundation for TME reconstruction by 3D bioprinting, which encompasses bioink design, printing strategies, and the construction of complex tumor models. We subsequently summarize its applications in tumor biology, drug screening, personalized therapy and preclinical evaluation, and discuss translational challenges, interdisciplinary integration and future research directions. This review is intended to advance both basic cancer research and precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, China.
- School of Medicine, Northwest University, Xi'an, Shaanxi, China.
ORCID-Profile: Ling-Jun Yao, Teng Qi
Zitieren
APA
Yao, L. J., Xie, P. L., Huang, T. X., Xiao, J. S., Zhu, Z. T., Liu, S., Wang, T. Y., & Qi, T. (2026). 3D Bioprinting for Tumor Microenvironment Reconstruction: Advances, Challenges, and Future Perspectives. Biotechnology Journal. https://doi.org/10.1002/biot.70267
Vancouver
Yao LJ, Xie PL, Huang TX, Xiao JS, Zhu ZT, Liu S, et al. 3D Bioprinting for Tumor Microenvironment Reconstruction: Advances, Challenges, and Future Perspectives. Biotechnology Journal. 2026. doi:10.1002/biot.70267
BibTeX
@article{Yao2026,
author = {Yao, Ling-Jun and Xie, Pei-Lin and Huang, Ting-Xuan and Xiao, Jin-Suo and Zhu, Zhen-Tao and Liu, Sui and Wang, Ting-Yu and Qi, Teng},
title = {3D Bioprinting for Tumor Microenvironment Reconstruction: Advances, Challenges, and Future Perspectives},
journal = {Biotechnology Journal},
year = {2026},
doi = {10.1002/biot.70267}
}
EUVIMED